山東路橋(000498.SZ):子公司聯合體中標125.52億元高速公路項目
格隆匯7月6日丨山東路橋(000498.SZ)公佈,近日,公司子公司路橋集團作為牽頭方與中鐵十四局等組成的聯合體被確定為濟南繞城高速公路二環線西環段工程設計施工總承包項目一標段(DXH-SJSG)第一中標候選人。招標人對上述評標結果進行了公示。
目前,上述項目定標工作已經完成,招標單位發佈了《濟南繞城高速公路二環線西環段工程設計施工總承包招標中標結果》。根據招標單位山東高速建設管理集團有限公司發佈的招標中標結果,該項目設計施工總承包一標段(DXH-SJSG)中標單位為牽頭方路橋集團、聯合方中鐵十四局等組成的聯合體,中標價約為125.52億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.